nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—GPR55—blood—hematologic cancer	0.0727	0.412	CbGeAlD
Bisacodyl—GPR55—testis—hematologic cancer	0.0601	0.341	CbGeAlD
Bisacodyl—GPR55—lymph node—hematologic cancer	0.0436	0.247	CbGeAlD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCR5—hematologic cancer	0.00511	0.0222	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CCR7—hematologic cancer	0.00452	0.0196	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCL13—hematologic cancer	0.00452	0.0196	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL17—hematologic cancer	0.00414	0.018	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—LPAR1—hematologic cancer	0.00407	0.0176	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCR5—hematologic cancer	0.00407	0.0176	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CNR2—hematologic cancer	0.00374	0.0162	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCL13—hematologic cancer	0.00359	0.0156	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCR7—hematologic cancer	0.00359	0.0156	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—ADCY7—hematologic cancer	0.00352	0.0153	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—TRH—hematologic cancer	0.00334	0.0145	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—LPAR1—hematologic cancer	0.00323	0.014	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL17—hematologic cancer	0.00315	0.0137	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCR5—hematologic cancer	0.0031	0.0134	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CNR2—hematologic cancer	0.00298	0.0129	CbGpPWpGaD
Bisacodyl—GPR55—G alpha (i) signalling events—CXCR4—hematologic cancer	0.00274	0.0119	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCR7—hematologic cancer	0.00274	0.0119	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCL13—hematologic cancer	0.00274	0.0119	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL3—hematologic cancer	0.00256	0.0111	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—TRH—hematologic cancer	0.00254	0.011	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—PTGER4—hematologic cancer	0.00246	0.0107	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—LPAR1—hematologic cancer	0.00246	0.0107	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CNR2—hematologic cancer	0.00227	0.00982	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CXCR4—hematologic cancer	0.00218	0.00943	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RHOJ—hematologic cancer	0.00208	0.00903	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ARHGEF12—hematologic cancer	0.00204	0.00884	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ARHGEF1—hematologic cancer	0.00199	0.00861	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL3—hematologic cancer	0.00195	0.00845	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—PTHLH—hematologic cancer	0.00193	0.00835	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—PTGER4—hematologic cancer	0.00188	0.00813	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IFT172—hematologic cancer	0.00186	0.00804	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ARHGEF12—hematologic cancer	0.00185	0.00803	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ARHGEF1—hematologic cancer	0.00181	0.00782	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCR5—hematologic cancer	0.00175	0.00758	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PPEF1—hematologic cancer	0.0017	0.00736	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GNA13—hematologic cancer	0.00169	0.00732	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—TIAM1—hematologic cancer	0.00166	0.0072	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CXCR4—hematologic cancer	0.00166	0.00718	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL17—hematologic cancer	0.00162	0.00702	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—JAK3—hematologic cancer	0.00161	0.00699	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCR5—hematologic cancer	0.00159	0.00689	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CCR7—hematologic cancer	0.00155	0.0067	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCL13—hematologic cancer	0.00155	0.0067	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GNA13—hematologic cancer	0.00153	0.00665	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—TIAM1—hematologic cancer	0.00151	0.00654	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—IL3RA—hematologic cancer	0.00151	0.00653	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—JAK3—hematologic cancer	0.00146	0.00634	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—RGS2—hematologic cancer	0.00145	0.0063	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—TRH—hematologic cancer	0.00144	0.00623	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—TRIO—hematologic cancer	0.00144	0.00623	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCL13—hematologic cancer	0.0014	0.00608	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCR7—hematologic cancer	0.0014	0.00608	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—LPAR1—hematologic cancer	0.00139	0.00603	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL3RA—hematologic cancer	0.00137	0.00593	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HDAC11—hematologic cancer	0.00134	0.00582	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—RGS2—hematologic cancer	0.00132	0.00572	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—TRIO—hematologic cancer	0.00131	0.00565	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—TRH—hematologic cancer	0.00131	0.00565	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—BCR—hematologic cancer	0.00129	0.00558	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PDE4B—hematologic cancer	0.00128	0.00555	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CNR2—hematologic cancer	0.00128	0.00555	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—LPAR1—hematologic cancer	0.00126	0.00548	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—RAC2—hematologic cancer	0.00126	0.00546	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—ADCY7—hematologic cancer	0.0012	0.00522	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HDAC10—hematologic cancer	0.0012	0.00518	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PDE4B—hematologic cancer	0.00116	0.00504	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CNR2—hematologic cancer	0.00116	0.00504	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—RAC2—hematologic cancer	0.00114	0.00496	CbGpPWpGaD
Bisacodyl—GPR55—Class A/1 (Rhodopsin-like receptors)—CCL2—hematologic cancer	0.00114	0.00494	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ARHGEF12—hematologic cancer	0.00109	0.00474	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—ADCY7—hematologic cancer	0.00109	0.00474	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PTHLH—hematologic cancer	0.00109	0.00472	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—ARHGEF1—hematologic cancer	0.00107	0.00462	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PTGER4—hematologic cancer	0.00106	0.00459	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CCL3—hematologic cancer	0.001	0.00433	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PTHLH—hematologic cancer	0.000989	0.00429	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PTGER4—hematologic cancer	0.000963	0.00417	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AGRN—hematologic cancer	0.000956	0.00414	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL17—hematologic cancer	0.000956	0.00414	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCR5—hematologic cancer	0.000939	0.00407	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CXCR4—hematologic cancer	0.000937	0.00406	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—LEF1—hematologic cancer	0.000922	0.004	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—GNA13—hematologic cancer	0.000907	0.00393	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—IL3—hematologic cancer	0.000903	0.00391	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TIAM1—hematologic cancer	0.000892	0.00386	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—RASGRP1—hematologic cancer	0.000873	0.00378	CbGpPWpGaD
Bisacodyl—GPR55—GPCR ligand binding—CCL2—hematologic cancer	0.000869	0.00376	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—JAK3—hematologic cancer	0.000865	0.00375	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—CXCR4—hematologic cancer	0.000851	0.00369	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCR7—hematologic cancer	0.000829	0.00359	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CXCL13—hematologic cancer	0.000829	0.00359	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL3—hematologic cancer	0.00082	0.00355	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NCOR2—hematologic cancer	0.000818	0.00355	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL3RA—hematologic cancer	0.000808	0.0035	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CRKL—hematologic cancer	0.000808	0.0035	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—RASGRP1—hematologic cancer	0.000793	0.00344	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—GRB2—hematologic cancer	0.000786	0.0034	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RGS2—hematologic cancer	0.00078	0.00338	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TRH—hematologic cancer	0.000771	0.00334	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TRIO—hematologic cancer	0.000771	0.00334	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CMA1—hematologic cancer	0.000771	0.00334	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AGO2—hematologic cancer	0.000754	0.00327	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SPHK1—hematologic cancer	0.000754	0.00327	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HDAC9—hematologic cancer	0.000747	0.00324	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—LPAR1—hematologic cancer	0.000747	0.00324	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—H3F3B—hematologic cancer	0.000739	0.0032	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—GRB2—hematologic cancer	0.000713	0.00309	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—CSF2—hematologic cancer	0.000702	0.00304	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PDE4B—hematologic cancer	0.000687	0.00298	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CNR2—hematologic cancer	0.000687	0.00298	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FGF19—hematologic cancer	0.000682	0.00295	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PRKCG—hematologic cancer	0.000677	0.00294	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—JAK1—hematologic cancer	0.000677	0.00294	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RAC2—hematologic cancer	0.000676	0.00293	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—DKK1—hematologic cancer	0.000671	0.00291	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—STAT5B—hematologic cancer	0.000666	0.00288	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Irinotecan—hematologic cancer	0.000663	0.00112	CcSEcCtD
Bisacodyl—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000662	0.00112	CcSEcCtD
Bisacodyl—Muscle spasms—Etoposide—hematologic cancer	0.000662	0.00112	CcSEcCtD
Bisacodyl—Headache—Nilotinib—hematologic cancer	0.000659	0.00111	CcSEcCtD
Bisacodyl—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000658	0.00111	CcSEcCtD
Bisacodyl—Headache—Imatinib—hematologic cancer	0.000655	0.00111	CcSEcCtD
Bisacodyl—Vomiting—Cladribine—hematologic cancer	0.000654	0.0011	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Thalidomide—hematologic cancer	0.000653	0.0011	CcSEcCtD
Bisacodyl—Dizziness—Vinblastine—hematologic cancer	0.000652	0.0011	CcSEcCtD
Bisacodyl—Abdominal pain—Vinorelbine—hematologic cancer	0.000648	0.00109	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—ADCY7—hematologic cancer	0.000646	0.0028	CbGpPWpGaD
Bisacodyl—Nervous system disorder—Gemcitabine—hematologic cancer	0.000645	0.00109	CcSEcCtD
Bisacodyl—Headache—Cladribine—hematologic cancer	0.000644	0.00109	CcSEcCtD
Bisacodyl—Diarrhoea—Melphalan—hematologic cancer	0.000642	0.00108	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Thiotepa—hematologic cancer	0.00064	0.00108	CcSEcCtD
Bisacodyl—Nausea—Chlorambucil—hematologic cancer	0.000639	0.00108	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CSF2—hematologic cancer	0.000637	0.00276	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—IL2RA—hematologic cancer	0.000633	0.00274	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—XIAP—hematologic cancer	0.000628	0.00272	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Carmustine—hematologic cancer	0.000627	0.00106	CcSEcCtD
Bisacodyl—Vomiting—Vinblastine—hematologic cancer	0.000627	0.00106	CcSEcCtD
Bisacodyl—Nausea—Nilotinib—hematologic cancer	0.000625	0.00105	CcSEcCtD
Bisacodyl—Diarrhoea—Lenalidomide—hematologic cancer	0.000624	0.00105	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Alitretinoin—hematologic cancer	0.000622	0.00105	CcSEcCtD
Bisacodyl—Nausea—Imatinib—hematologic cancer	0.000621	0.00105	CcSEcCtD
Bisacodyl—Angioedema—Prednisolone—hematologic cancer	0.000621	0.00105	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Thalidomide—hematologic cancer	0.000619	0.00104	CcSEcCtD
Bisacodyl—Abdominal pain—Thiotepa—hematologic cancer	0.000618	0.00104	CcSEcCtD
Bisacodyl—Hypersensitivity—Bortezomib—hematologic cancer	0.000618	0.00104	CcSEcCtD
Bisacodyl—Headache—Vinblastine—hematologic cancer	0.000618	0.00104	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PRKCG—hematologic cancer	0.000615	0.00267	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—JAK1—hematologic cancer	0.000615	0.00267	CbGpPWpGaD
Bisacodyl—Diarrhoea—Hydroxyurea—hematologic cancer	0.000615	0.00104	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Ifosfamide—hematologic cancer	0.000614	0.00104	CcSEcCtD
Bisacodyl—Anaphylactic shock—Cisplatin—hematologic cancer	0.000613	0.00103	CcSEcCtD
Bisacodyl—Hypersensitivity—Bleomycin—hematologic cancer	0.000613	0.00103	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—SH2B3—hematologic cancer	0.000612	0.00265	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SMARCA4—hematologic cancer	0.000612	0.00265	CbGpPWpGaD
Bisacodyl—Nausea—Cladribine—hematologic cancer	0.000611	0.00103	CcSEcCtD
Bisacodyl—Syncope—Prednisolone—hematologic cancer	0.000609	0.00103	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—GZMB—hematologic cancer	0.000609	0.00264	CbGpPWpGaD
Bisacodyl—Loss of consciousness—Etoposide—hematologic cancer	0.000605	0.00102	CcSEcCtD
Bisacodyl—Hypersensitivity—Vinorelbine—hematologic cancer	0.000604	0.00102	CcSEcCtD
Bisacodyl—Dizziness—Lenalidomide—hematologic cancer	0.000603	0.00102	CcSEcCtD
Bisacodyl—Nervous system disorder—Cisplatin—hematologic cancer	0.000602	0.00101	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Vincristine—hematologic cancer	0.000599	0.00101	CcSEcCtD
Bisacodyl—Abdominal pain—Thalidomide—hematologic cancer	0.000598	0.00101	CcSEcCtD
Bisacodyl—Loss of consciousness—Prednisolone—hematologic cancer	0.000597	0.00101	CcSEcCtD
Bisacodyl—Vomiting—Melphalan—hematologic cancer	0.000596	0.00101	CcSEcCtD
Bisacodyl—Dehydration—Epirubicin—hematologic cancer	0.000596	0.00101	CcSEcCtD
Bisacodyl—Dizziness—Hydroxyurea—hematologic cancer	0.000594	0.001	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CTNNA1—hematologic cancer	0.000594	0.00258	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Carmustine—hematologic cancer	0.000594	0.001	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—EIF4EBP1—hematologic cancer	0.000591	0.00256	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL3—hematologic cancer	0.000591	0.00256	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HSPB1—hematologic cancer	0.000591	0.00256	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Alitretinoin—hematologic cancer	0.000589	0.000993	CcSEcCtD
Bisacodyl—Nausea—Vinblastine—hematologic cancer	0.000586	0.000988	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PTHLH—hematologic cancer	0.000584	0.00253	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SDC1—hematologic cancer	0.000584	0.00253	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000583	0.000984	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Ifosfamide—hematologic cancer	0.000582	0.000981	CcSEcCtD
Bisacodyl—Vomiting—Lenalidomide—hematologic cancer	0.00058	0.000978	CcSEcCtD
Bisacodyl—Hypersensitivity—Thiotepa—hematologic cancer	0.000576	0.000972	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—IL2RA—hematologic cancer	0.000575	0.00249	CbGpPWpGaD
Bisacodyl—Abdominal pain—Carmustine—hematologic cancer	0.000574	0.000969	CcSEcCtD
Bisacodyl—Diarrhoea—Bortezomib—hematologic cancer	0.000574	0.000968	CcSEcCtD
Bisacodyl—Vomiting—Hydroxyurea—hematologic cancer	0.000572	0.000964	CcSEcCtD
Bisacodyl—Headache—Lenalidomide—hematologic cancer	0.000571	0.000963	CcSEcCtD
Bisacodyl—Angioedema—Triamcinolone—hematologic cancer	0.000571	0.000963	CcSEcCtD
Bisacodyl—Abdominal pain—Alitretinoin—hematologic cancer	0.000569	0.00096	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PTGER4—hematologic cancer	0.000569	0.00246	CbGpPWpGaD
Bisacodyl—Gastrointestinal disorder—Gemcitabine—hematologic cancer	0.000568	0.000958	CcSEcCtD
Bisacodyl—Abdominal discomfort—Methotrexate—hematologic cancer	0.000567	0.000957	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Vincristine—hematologic cancer	0.000567	0.000957	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—LCK—hematologic cancer	0.000566	0.00245	CbGpPWpGaD
Bisacodyl—Headache—Hydroxyurea—hematologic cancer	0.000563	0.00095	CcSEcCtD
Bisacodyl—Abdominal pain—Ifosfamide—hematologic cancer	0.000562	0.000949	CcSEcCtD
Bisacodyl—Anaphylactic shock—Etoposide—hematologic cancer	0.000562	0.000948	CcSEcCtD
Bisacodyl—Diarrhoea—Vinorelbine—hematologic cancer	0.00056	0.000945	CcSEcCtD
Bisacodyl—Syncope—Triamcinolone—hematologic cancer	0.00056	0.000945	CcSEcCtD
Bisacodyl—Hypersensitivity—Thalidomide—hematologic cancer	0.000557	0.00094	CcSEcCtD
Bisacodyl—Nausea—Melphalan—hematologic cancer	0.000557	0.000939	CcSEcCtD
Bisacodyl—Dizziness—Bortezomib—hematologic cancer	0.000555	0.000936	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—H3F3A—hematologic cancer	0.000555	0.0024	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Prednisolone—hematologic cancer	0.000554	0.000935	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Mitoxantrone—hematologic cancer	0.000552	0.000932	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Irinotecan—hematologic cancer	0.000552	0.000932	CcSEcCtD
Bisacodyl—Dehydration—Doxorubicin—hematologic cancer	0.000552	0.00093	CcSEcCtD
Bisacodyl—Loss of consciousness—Triamcinolone—hematologic cancer	0.000549	0.000926	CcSEcCtD
Bisacodyl—Abdominal pain—Vincristine—hematologic cancer	0.000548	0.000925	CcSEcCtD
Bisacodyl—Shock—Prednisolone—hematologic cancer	0.000545	0.00092	CcSEcCtD
Bisacodyl—Dizziness—Vinorelbine—hematologic cancer	0.000542	0.000914	CcSEcCtD
Bisacodyl—Nausea—Lenalidomide—hematologic cancer	0.000542	0.000913	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PRKCZ—hematologic cancer	0.000539	0.00234	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Carmustine—hematologic cancer	0.000535	0.000903	CcSEcCtD
Bisacodyl—Diarrhoea—Thiotepa—hematologic cancer	0.000535	0.000903	CcSEcCtD
Bisacodyl—Abdominal pain—Mitoxantrone—hematologic cancer	0.000534	0.000901	CcSEcCtD
Bisacodyl—Abdominal pain—Irinotecan—hematologic cancer	0.000534	0.000901	CcSEcCtD
Bisacodyl—Nausea—Hydroxyurea—hematologic cancer	0.000534	0.000901	CcSEcCtD
Bisacodyl—Vomiting—Bortezomib—hematologic cancer	0.000533	0.0009	CcSEcCtD
Bisacodyl—Hypersensitivity—Alitretinoin—hematologic cancer	0.00053	0.000895	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Cisplatin—hematologic cancer	0.00053	0.000893	CcSEcCtD
Bisacodyl—Vomiting—Bleomycin—hematologic cancer	0.000529	0.000893	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3CG—hematologic cancer	0.000527	0.00228	CbGpPWpGaD
Bisacodyl—Headache—Bortezomib—hematologic cancer	0.000526	0.000887	CcSEcCtD
Bisacodyl—Hypersensitivity—Ifosfamide—hematologic cancer	0.000524	0.000884	CcSEcCtD
Bisacodyl—Vomiting—Vinorelbine—hematologic cancer	0.000521	0.000879	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PARP1—hematologic cancer	0.000521	0.00226	CbGpPWpGaD
Bisacodyl—Angioedema—Dexamethasone—hematologic cancer	0.000518	0.000873	CcSEcCtD
Bisacodyl—Angioedema—Betamethasone—hematologic cancer	0.000518	0.000873	CcSEcCtD
Bisacodyl—Diarrhoea—Thalidomide—hematologic cancer	0.000518	0.000873	CcSEcCtD
Bisacodyl—Dizziness—Thiotepa—hematologic cancer	0.000517	0.000873	CcSEcCtD
Bisacodyl—Headache—Vinorelbine—hematologic cancer	0.000513	0.000866	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—FBXW7—hematologic cancer	0.000512	0.00222	CbGpPWpGaD
Bisacodyl—Immune system disorder—Prednisone—hematologic cancer	0.000512	0.000864	CcSEcCtD
Bisacodyl—Hypersensitivity—Vincristine—hematologic cancer	0.000511	0.000862	CcSEcCtD
Bisacodyl—Anaphylactic shock—Triamcinolone—hematologic cancer	0.00051	0.00086	CcSEcCtD
Bisacodyl—Syncope—Betamethasone—hematologic cancer	0.000508	0.000857	CcSEcCtD
Bisacodyl—Syncope—Dexamethasone—hematologic cancer	0.000508	0.000857	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CXCR4—hematologic cancer	0.000502	0.00218	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HDAC2—hematologic cancer	0.000502	0.00218	CbGpPWpGaD
Bisacodyl—Shock—Triamcinolone—hematologic cancer	0.000501	0.000846	CcSEcCtD
Bisacodyl—Dizziness—Thalidomide—hematologic cancer	0.0005	0.000844	CcSEcCtD
Bisacodyl—Nausea—Bortezomib—hematologic cancer	0.000498	0.000841	CcSEcCtD
Bisacodyl—Loss of consciousness—Betamethasone—hematologic cancer	0.000498	0.00084	CcSEcCtD
Bisacodyl—Loss of consciousness—Dexamethasone—hematologic cancer	0.000498	0.00084	CcSEcCtD
Bisacodyl—Hypersensitivity—Irinotecan—hematologic cancer	0.000498	0.00084	CcSEcCtD
Bisacodyl—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000498	0.00084	CcSEcCtD
Bisacodyl—Vomiting—Thiotepa—hematologic cancer	0.000497	0.000839	CcSEcCtD
Bisacodyl—Diarrhoea—Carmustine—hematologic cancer	0.000497	0.000839	CcSEcCtD
Bisacodyl—Nausea—Bleomycin—hematologic cancer	0.000495	0.000834	CcSEcCtD
Bisacodyl—Malnutrition—Prednisone—hematologic cancer	0.000494	0.000832	CcSEcCtD
Bisacodyl—Diarrhoea—Alitretinoin—hematologic cancer	0.000493	0.000831	CcSEcCtD
Bisacodyl—Headache—Thiotepa—hematologic cancer	0.00049	0.000827	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CBL—hematologic cancer	0.00049	0.00212	CbGpPWpGaD
Bisacodyl—Diarrhoea—Ifosfamide—hematologic cancer	0.000487	0.000821	CcSEcCtD
Bisacodyl—Nausea—Vinorelbine—hematologic cancer	0.000487	0.000821	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000485	0.000818	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—IL3—hematologic cancer	0.000484	0.0021	CbGpPWpGaD
Bisacodyl—Vomiting—Thalidomide—hematologic cancer	0.000481	0.000812	CcSEcCtD
Bisacodyl—Dizziness—Carmustine—hematologic cancer	0.000481	0.000811	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PIK3CG—hematologic cancer	0.000479	0.00207	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PTPN1—hematologic cancer	0.000476	0.00206	CbGpPWpGaD
Bisacodyl—Dizziness—Alitretinoin—hematologic cancer	0.000476	0.000803	CcSEcCtD
Bisacodyl—Diarrhoea—Vincristine—hematologic cancer	0.000475	0.000801	CcSEcCtD
Bisacodyl—Headache—Thalidomide—hematologic cancer	0.000474	0.0008	CcSEcCtD
Bisacodyl—Dizziness—Ifosfamide—hematologic cancer	0.000471	0.000794	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PTPN11—hematologic cancer	0.00047	0.00204	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—RASGRP1—hematologic cancer	0.000469	0.00203	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HSP90AA1—hematologic cancer	0.000467	0.00202	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SYK—hematologic cancer	0.000467	0.00202	CbGpPWpGaD
Bisacodyl—Nausea—Thiotepa—hematologic cancer	0.000465	0.000784	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3CD—hematologic cancer	0.000463	0.00201	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000462	0.00078	CcSEcCtD
Bisacodyl—Anaphylactic shock—Betamethasone—hematologic cancer	0.000462	0.00078	CcSEcCtD
Bisacodyl—Diarrhoea—Mitoxantrone—hematologic cancer	0.000462	0.00078	CcSEcCtD
Bisacodyl—Diarrhoea—Irinotecan—hematologic cancer	0.000462	0.00078	CcSEcCtD
Bisacodyl—Vomiting—Carmustine—hematologic cancer	0.000462	0.000779	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Etoposide—hematologic cancer	0.00046	0.000775	CcSEcCtD
Bisacodyl—Dizziness—Vincristine—hematologic cancer	0.000459	0.000774	CcSEcCtD
Bisacodyl—Vomiting—Alitretinoin—hematologic cancer	0.000458	0.000772	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CREB1—hematologic cancer	0.000456	0.00197	CbGpPWpGaD
Bisacodyl—Headache—Carmustine—hematologic cancer	0.000455	0.000768	CcSEcCtD
Bisacodyl—Shock—Betamethasone—hematologic cancer	0.000455	0.000768	CcSEcCtD
Bisacodyl—Shock—Dexamethasone—hematologic cancer	0.000455	0.000768	CcSEcCtD
Bisacodyl—Nervous system disorder—Betamethasone—hematologic cancer	0.000454	0.000765	CcSEcCtD
Bisacodyl—Nervous system disorder—Dexamethasone—hematologic cancer	0.000454	0.000765	CcSEcCtD
Bisacodyl—Vomiting—Ifosfamide—hematologic cancer	0.000452	0.000763	CcSEcCtD
Bisacodyl—Hypersensitivity—Cisplatin—hematologic cancer	0.000452	0.000762	CcSEcCtD
Bisacodyl—Headache—Alitretinoin—hematologic cancer	0.000451	0.000761	CcSEcCtD
Bisacodyl—Angioedema—Prednisone—hematologic cancer	0.000451	0.000761	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—STAT1—hematologic cancer	0.00045	0.00195	CbGpPWpGaD
Bisacodyl—Diarrhoea—Gemcitabine—hematologic cancer	0.00045	0.00076	CcSEcCtD
Bisacodyl—Nausea—Thalidomide—hematologic cancer	0.000449	0.000758	CcSEcCtD
Bisacodyl—Dizziness—Irinotecan—hematologic cancer	0.000447	0.000754	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—CCL2—hematologic cancer	0.000446	0.00193	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL6R—hematologic cancer	0.000444	0.00193	CbGpPWpGaD
Bisacodyl—Abdominal pain—Etoposide—hematologic cancer	0.000444	0.000749	CcSEcCtD
Bisacodyl—Syncope—Prednisone—hematologic cancer	0.000443	0.000747	CcSEcCtD
Bisacodyl—Vomiting—Vincristine—hematologic cancer	0.000441	0.000744	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3R1—hematologic cancer	0.000438	0.0019	CbGpPWpGaD
Bisacodyl—Headache—Vincristine—hematologic cancer	0.000435	0.000733	CcSEcCtD
Bisacodyl—Loss of consciousness—Prednisone—hematologic cancer	0.000434	0.000732	CcSEcCtD
Bisacodyl—Nausea—Carmustine—hematologic cancer	0.000432	0.000728	CcSEcCtD
Bisacodyl—Vomiting—Irinotecan—hematologic cancer	0.00043	0.000725	CcSEcCtD
Bisacodyl—Vomiting—Mitoxantrone—hematologic cancer	0.00043	0.000725	CcSEcCtD
Bisacodyl—Immune system disorder—Methotrexate—hematologic cancer	0.000428	0.000722	CcSEcCtD
Bisacodyl—Nausea—Alitretinoin—hematologic cancer	0.000428	0.000721	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—JAK2—hematologic cancer	0.000425	0.00184	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—MAP2K1—hematologic cancer	0.000424	0.00184	CbGpPWpGaD
Bisacodyl—Headache—Mitoxantrone—hematologic cancer	0.000423	0.000714	CcSEcCtD
Bisacodyl—Headache—Irinotecan—hematologic cancer	0.000423	0.000714	CcSEcCtD
Bisacodyl—Nausea—Ifosfamide—hematologic cancer	0.000423	0.000713	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—GRB2—hematologic cancer	0.000421	0.00183	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PIK3CD—hematologic cancer	0.000421	0.00182	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PDGFA—hematologic cancer	0.00042	0.00182	CbGpPWpGaD
Bisacodyl—Diarrhoea—Cisplatin—hematologic cancer	0.00042	0.000708	CcSEcCtD
Bisacodyl—Vomiting—Gemcitabine—hematologic cancer	0.000418	0.000706	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—KITLG—hematologic cancer	0.000414	0.0018	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Etoposide—hematologic cancer	0.000414	0.000698	CcSEcCtD
Bisacodyl—Malnutrition—Methotrexate—hematologic cancer	0.000412	0.000696	CcSEcCtD
Bisacodyl—Headache—Gemcitabine—hematologic cancer	0.000412	0.000695	CcSEcCtD
Bisacodyl—Nausea—Vincristine—hematologic cancer	0.000412	0.000695	CcSEcCtD
Bisacodyl—Hypersensitivity—Prednisolone—hematologic cancer	0.000408	0.000689	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—STAT5A—hematologic cancer	0.000405	0.00175	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3CB—hematologic cancer	0.000404	0.00175	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Prednisone—hematologic cancer	0.000403	0.000679	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CDKN2B—hematologic cancer	0.000401	0.00174	CbGpPWpGaD
Bisacodyl—Nausea—Irinotecan—hematologic cancer	0.000401	0.000677	CcSEcCtD
Bisacodyl—Nausea—Mitoxantrone—hematologic cancer	0.000401	0.000677	CcSEcCtD
Bisacodyl—Immune system disorder—Epirubicin—hematologic cancer	0.0004	0.000676	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000399	0.000674	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000399	0.000674	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—PIK3R1—hematologic cancer	0.000397	0.00172	CbGpPWpGaD
Bisacodyl—Shock—Prednisone—hematologic cancer	0.000396	0.000668	CcSEcCtD
Bisacodyl—Nervous system disorder—Prednisone—hematologic cancer	0.000395	0.000666	CcSEcCtD
Bisacodyl—Nausea—Gemcitabine—hematologic cancer	0.000391	0.000659	CcSEcCtD
Bisacodyl—Vomiting—Cisplatin—hematologic cancer	0.00039	0.000658	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CD86—hematologic cancer	0.000388	0.00168	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—JAK2—hematologic cancer	0.000386	0.00167	CbGpPWpGaD
Bisacodyl—Malnutrition—Epirubicin—hematologic cancer	0.000386	0.000651	CcSEcCtD
Bisacodyl—Diarrhoea—Etoposide—hematologic cancer	0.000384	0.000649	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—HES1—hematologic cancer	0.000383	0.00166	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NCOR1—hematologic cancer	0.000381	0.00165	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000378	0.000638	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000378	0.000638	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CSF2—hematologic cancer	0.000377	0.00163	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—FGF1—hematologic cancer	0.000377	0.00163	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Triamcinolone—hematologic cancer	0.000376	0.000633	CcSEcCtD
Bisacodyl—Dizziness—Etoposide—hematologic cancer	0.000372	0.000627	CcSEcCtD
Bisacodyl—Muscle spasms—Epirubicin—hematologic cancer	0.000371	0.000626	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—FOXO1—hematologic cancer	0.000371	0.00161	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—IL2—hematologic cancer	0.000371	0.00161	CbGpPWpGaD
Bisacodyl—Immune system disorder—Doxorubicin—hematologic cancer	0.000371	0.000625	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PDGFRB—hematologic cancer	0.00037	0.0016	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PIK3CB—hematologic cancer	0.000367	0.00159	CbGpPWpGaD
Bisacodyl—Dizziness—Prednisolone—hematologic cancer	0.000367	0.000618	CcSEcCtD
Bisacodyl—Abdominal pain—Dexamethasone—hematologic cancer	0.000366	0.000617	CcSEcCtD
Bisacodyl—Abdominal pain—Betamethasone—hematologic cancer	0.000366	0.000617	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PDGFRA—hematologic cancer	0.000365	0.00158	CbGpPWpGaD
Bisacodyl—Nausea—Cisplatin—hematologic cancer	0.000364	0.000615	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PRKCG—hematologic cancer	0.000363	0.00157	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—JAK1—hematologic cancer	0.000363	0.00157	CbGpPWpGaD
Bisacodyl—Vomiting—Etoposide—hematologic cancer	0.000357	0.000603	CcSEcCtD
Bisacodyl—Malnutrition—Doxorubicin—hematologic cancer	0.000357	0.000602	CcSEcCtD
Bisacodyl—Headache—Etoposide—hematologic cancer	0.000352	0.000594	CcSEcCtD
Bisacodyl—Headache—Prednisolone—hematologic cancer	0.000347	0.000586	CcSEcCtD
Bisacodyl—Syncope—Epirubicin—hematologic cancer	0.000346	0.000584	CcSEcCtD
Bisacodyl—Muscle spasms—Doxorubicin—hematologic cancer	0.000343	0.000579	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—IL2RA—hematologic cancer	0.000339	0.00147	CbGpPWpGaD
Bisacodyl—Loss of consciousness—Epirubicin—hematologic cancer	0.000339	0.000572	CcSEcCtD
Bisacodyl—Dizziness—Triamcinolone—hematologic cancer	0.000337	0.000569	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—IL2—hematologic cancer	0.000337	0.00146	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Methotrexate—hematologic cancer	0.000337	0.000568	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—TERT—hematologic cancer	0.000336	0.00145	CbGpPWpGaD
Bisacodyl—Nausea—Etoposide—hematologic cancer	0.000334	0.000563	CcSEcCtD
Bisacodyl—Nervous system disorder—Methotrexate—hematologic cancer	0.00033	0.000557	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Prednisone—hematologic cancer	0.000329	0.000556	CcSEcCtD
Bisacodyl—Nausea—Prednisolone—hematologic cancer	0.000329	0.000555	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PDGFB—hematologic cancer	0.000328	0.00142	CbGpPWpGaD
Bisacodyl—Vomiting—Triamcinolone—hematologic cancer	0.000324	0.000547	CcSEcCtD
Bisacodyl—Syncope—Doxorubicin—hematologic cancer	0.00032	0.00054	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—TSC2—hematologic cancer	0.00032	0.00139	CbGpPWpGaD
Bisacodyl—Headache—Triamcinolone—hematologic cancer	0.000319	0.000539	CcSEcCtD
Bisacodyl—Abdominal pain—Prednisone—hematologic cancer	0.000318	0.000537	CcSEcCtD
Bisacodyl—Diarrhoea—Dexamethasone—hematologic cancer	0.000316	0.000534	CcSEcCtD
Bisacodyl—Diarrhoea—Betamethasone—hematologic cancer	0.000316	0.000534	CcSEcCtD
Bisacodyl—Anaphylactic shock—Epirubicin—hematologic cancer	0.000315	0.000531	CcSEcCtD
Bisacodyl—Loss of consciousness—Doxorubicin—hematologic cancer	0.000314	0.000529	CcSEcCtD
Bisacodyl—Shock—Epirubicin—hematologic cancer	0.00031	0.000523	CcSEcCtD
Bisacodyl—Nervous system disorder—Epirubicin—hematologic cancer	0.000309	0.000521	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—FGFR3—hematologic cancer	0.000308	0.00133	CbGpPWpGaD
Bisacodyl—Dizziness—Dexamethasone—hematologic cancer	0.000306	0.000516	CcSEcCtD
Bisacodyl—Dizziness—Betamethasone—hematologic cancer	0.000306	0.000516	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—MAPK14—hematologic cancer	0.000305	0.00132	CbGpPWpGaD
Bisacodyl—Nausea—Triamcinolone—hematologic cancer	0.000303	0.000511	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—ESR1—hematologic cancer	0.000299	0.0013	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Prednisone—hematologic cancer	0.000297	0.000501	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—FN1—hematologic cancer	0.000295	0.00128	CbGpPWpGaD
Bisacodyl—Vomiting—Betamethasone—hematologic cancer	0.000294	0.000496	CcSEcCtD
Bisacodyl—Vomiting—Dexamethasone—hematologic cancer	0.000294	0.000496	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—BAD—hematologic cancer	0.000292	0.00126	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NFKBIA—hematologic cancer	0.000292	0.00126	CbGpPWpGaD
Bisacodyl—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000291	0.000492	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000291	0.00049	CcSEcCtD
Bisacodyl—Headache—Betamethasone—hematologic cancer	0.00029	0.000489	CcSEcCtD
Bisacodyl—Headache—Dexamethasone—hematologic cancer	0.00029	0.000489	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—NOTCH1—hematologic cancer	0.000289	0.00125	CbGpPWpGaD
Bisacodyl—Shock—Doxorubicin—hematologic cancer	0.000287	0.000484	CcSEcCtD
Bisacodyl—Nervous system disorder—Doxorubicin—hematologic cancer	0.000286	0.000482	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CD80—hematologic cancer	0.000283	0.00123	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PIK3CG—hematologic cancer	0.000283	0.00123	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—KIT—hematologic cancer	0.000283	0.00123	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—NRAS—hematologic cancer	0.000283	0.00123	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PTPN11—hematologic cancer	0.000278	0.0012	CbGpPWpGaD
Bisacodyl—Diarrhoea—Prednisone—hematologic cancer	0.000276	0.000465	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000275	0.000464	CcSEcCtD
Bisacodyl—Nausea—Dexamethasone—hematologic cancer	0.000275	0.000463	CcSEcCtD
Bisacodyl—Nausea—Betamethasone—hematologic cancer	0.000275	0.000463	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000272	0.000459	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—MAPK3—hematologic cancer	0.000271	0.00117	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CREB1—hematologic cancer	0.000269	0.00117	CbGpPWpGaD
Bisacodyl—Dizziness—Prednisone—hematologic cancer	0.000266	0.000449	CcSEcCtD
Bisacodyl—Abdominal pain—Methotrexate—hematologic cancer	0.000266	0.000449	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—BRAF—hematologic cancer	0.000266	0.00115	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CCL2—hematologic cancer	0.000263	0.00114	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL6R—hematologic cancer	0.000263	0.00114	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CREBBP—hematologic cancer	0.000262	0.00114	CbGpPWpGaD
Bisacodyl—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000258	0.000434	CcSEcCtD
Bisacodyl—Vomiting—Prednisone—hematologic cancer	0.000256	0.000432	CcSEcCtD
Bisacodyl—Headache—Prednisone—hematologic cancer	0.000252	0.000426	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000252	0.000424	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—MAP2K1—hematologic cancer	0.00025	0.00108	CbGpPWpGaD
Bisacodyl—Abdominal pain—Epirubicin—hematologic cancer	0.000249	0.00042	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PIK3CD—hematologic cancer	0.000249	0.00108	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Methotrexate—hematologic cancer	0.000248	0.000418	CcSEcCtD
Bisacodyl—GPR55—GPCR downstream signaling—PIK3CA—hematologic cancer	0.000246	0.00107	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—KRAS—hematologic cancer	0.000243	0.00105	CbGpPWpGaD
Bisacodyl—Nausea—Prednisone—hematologic cancer	0.000239	0.000404	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000238	0.000402	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—FGF2—hematologic cancer	0.000238	0.00103	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PIK3R1—hematologic cancer	0.000235	0.00102	CbGpPWpGaD
Bisacodyl—Hypersensitivity—Epirubicin—hematologic cancer	0.000232	0.000391	CcSEcCtD
Bisacodyl—Abdominal pain—Doxorubicin—hematologic cancer	0.00023	0.000389	CcSEcCtD
Bisacodyl—Diarrhoea—Methotrexate—hematologic cancer	0.00023	0.000388	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—JAK2—hematologic cancer	0.000228	0.000988	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—PIK3CA—hematologic cancer	0.000224	0.000969	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MDM2—hematologic cancer	0.000223	0.000965	CbGpPWpGaD
Bisacodyl—Dizziness—Methotrexate—hematologic cancer	0.000223	0.000375	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—PIK3CB—hematologic cancer	0.000217	0.000939	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MTOR—hematologic cancer	0.000217	0.000939	CbGpPWpGaD
Bisacodyl—Diarrhoea—Epirubicin—hematologic cancer	0.000216	0.000364	CcSEcCtD
Bisacodyl—Hypersensitivity—Doxorubicin—hematologic cancer	0.000215	0.000362	CcSEcCtD
Bisacodyl—Vomiting—Methotrexate—hematologic cancer	0.000214	0.000361	CcSEcCtD
Bisacodyl—Headache—Methotrexate—hematologic cancer	0.000211	0.000356	CcSEcCtD
Bisacodyl—Dizziness—Epirubicin—hematologic cancer	0.000208	0.000351	CcSEcCtD
Bisacodyl—GPR55—Signaling by GPCR—HRAS—hematologic cancer	0.000207	0.000896	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—CDKN1B—hematologic cancer	0.000203	0.000881	CbGpPWpGaD
Bisacodyl—GPR55—GPCR downstream signaling—AKT1—hematologic cancer	0.000201	0.000871	CbGpPWpGaD
Bisacodyl—Vomiting—Epirubicin—hematologic cancer	0.0002	0.000338	CcSEcCtD
Bisacodyl—Nausea—Methotrexate—hematologic cancer	0.0002	0.000337	CcSEcCtD
Bisacodyl—Diarrhoea—Doxorubicin—hematologic cancer	0.000199	0.000336	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CASP3—hematologic cancer	0.000199	0.000863	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL2—hematologic cancer	0.000199	0.000862	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—IL6—hematologic cancer	0.000198	0.000858	CbGpPWpGaD
Bisacodyl—Headache—Epirubicin—hematologic cancer	0.000197	0.000333	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CCND1—hematologic cancer	0.000194	0.00084	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—JUN—hematologic cancer	0.000194	0.000839	CbGpPWpGaD
Bisacodyl—Dizziness—Doxorubicin—hematologic cancer	0.000193	0.000325	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—CDKN1A—hematologic cancer	0.000188	0.000813	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PTEN—hematologic cancer	0.000187	0.000811	CbGpPWpGaD
Bisacodyl—Nausea—Epirubicin—hematologic cancer	0.000187	0.000316	CcSEcCtD
Bisacodyl—Vomiting—Doxorubicin—hematologic cancer	0.000185	0.000313	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—MAPK8—hematologic cancer	0.000183	0.000794	CbGpPWpGaD
Bisacodyl—GPR55—Signaling by GPCR—AKT1—hematologic cancer	0.000183	0.000791	CbGpPWpGaD
Bisacodyl—Headache—Doxorubicin—hematologic cancer	0.000183	0.000308	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—EP300—hematologic cancer	0.000179	0.000774	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—SRC—hematologic cancer	0.000174	0.000752	CbGpPWpGaD
Bisacodyl—Nausea—Doxorubicin—hematologic cancer	0.000173	0.000292	CcSEcCtD
Bisacodyl—GPR55—Signaling Pathways—VEGFA—hematologic cancer	0.000169	0.000733	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—STAT3—hematologic cancer	0.000167	0.000725	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—NRAS—hematologic cancer	0.000167	0.000724	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MAPK3—hematologic cancer	0.00016	0.000693	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—MYC—hematologic cancer	0.000156	0.000674	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TGFB1—hematologic cancer	0.000155	0.000672	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—KRAS—hematologic cancer	0.000144	0.000623	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—PIK3CA—hematologic cancer	0.000132	0.000572	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—TP53—hematologic cancer	0.000128	0.000554	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—HRAS—hematologic cancer	0.000122	0.000529	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—IL6—hematologic cancer	0.000117	0.000507	CbGpPWpGaD
Bisacodyl—GPR55—Signaling Pathways—AKT1—hematologic cancer	0.000108	0.000467	CbGpPWpGaD
